Received May 6, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8600A | — |
| MENB | MENINGOCOCCAL B (TRUMENBA) | PFIZER\WYETH | UNK | — | — |
sore neck with pain upon touching; numbness in the hands and feet; experienced severe headaches; Initial information received on 06-Apr-2026 regarding an unsolicited valid serious case received from a consumer (non-healthcare professional). This case involves a 17-year-old male patient who experienced sore neck with pain upon touching, numbness in the hands and feet, and experienced severe headaches after receiving Meningococcal A-C-Y-W135 (T Conj) Vaccine (Menquadfi) and Meningococcal vaccine B (pfizer MenB vaccines). The patient's past medical history, past drugs, vaccination(s), family history, and concomitant medications were not provided. On 01-Apr-2026, the patient received dose 2 of Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] Solution for injection (Batch/Lot Number: U8600A, Expiration Date: 31-Oct-2028) and received Meningococcal vaccine B not produced by Sanofi Pasteur (Batch/Lot Number, Formulation and Expiration Date: unknown), both with unknown strength via unknown route in an unknown administration site for prophylactic vaccination [Immunisation]. On 01-Apr-2026 around 18:00 to 19:00 hours, The patient experienced sore neck with pain upon touching (Neck pain), numbness in the hands and feet (Hypoaesthesia) and experienced severe headaches (Headache) (latency: approximately 8-9 hours). Action taken: Not reported. Corrective treatment: Not reported for all events. Event outcome: recovered/resolved on 02-APR-2026 for all events.
Comments: NONE